A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160???mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study
Year: 2002
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Authors: M. Arato, R. O??Connor, H.Y. Meltzer
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Pfizer
OpenAlex ID: W2063674695
